keyword
Keywords Machine learning algorithm for...

Machine learning algorithm for lung cancer prediction

https://read.qxmd.com/read/38166659/gcnformer-graph-convolutional-network-and-transformer-for-predicting-lncrna-disease-associations
#41
JOURNAL ARTICLE
Dengju Yao, Bailin Li, Xiaojuan Zhan, Xiaorong Zhan, Liyang Yu
BACKGROUND: A growing body of researches indicate that the disrupted expression of long non-coding RNA (lncRNA) is linked to a range of human disorders. Therefore, the effective prediction of lncRNA-disease association (LDA) can not only suggest solutions to diagnose a condition but also save significant time and labor costs. METHOD: In this work, we proposed a novel LDA predicting algorithm based on graph convolutional network and transformer, named GCNFORMER. Firstly, we integrated the intraclass similarity and interclass connections between miRNAs, lncRNAs and diseases, and built a graph adjacency matrix...
January 2, 2024: BMC Bioinformatics
https://read.qxmd.com/read/38162176/brief-report-circrunx1-as-potential-biomarker-for-cancer-recurrence-in-egfr-mutation-positive-surgically-resected-nsclc
#42
JOURNAL ARTICLE
Carlos Pedraz-Valdunciel, Masaoki Ito, Stavros Giannoukakos, Ana Giménez-Capitán, Miguel Ángel Molina-Vila, Rafael Rosell
INTRODUCTION: As recently evidenced by the ADAURA trial, most patients with stages IB to IIIA of resected EGFR-mutant lung adenocarcinoma benefit from osimertinib as adjuvant therapy. Nevertheless, predictive markers of response and recurrence are still an unmet need for more than 10% of these patients. Some circular RNAs (circRNAs) have been reported to play a role in tumor growth and proliferation. In this project, we studied circRNA expression levels in formalin-fixed, paraffin-embedded lung tumor samples to explore their biomarker potential and develop a machine learning (ML)-based signature that could predict the benefit of adjuvant EGFR tyrosine kinase inhibitors in patients with EGFR-mutant NSCLC...
December 2023: JTO clinical and research reports
https://read.qxmd.com/read/38156919/prediction-of-lymph-node-metastasis-of-lung-squamous-cell-carcinoma-by-machine-learning-algorithm-classifiers
#43
JOURNAL ARTICLE
Guosheng Li, Changqian Li, Jun Liu, Huajian Peng, Shuyu Lu, Donglin Wei, Jianji Guo, Meijing Wang, Nuo Yang
BACKGROUND: Lymph node metastasis (LNM) is an essential factor affecting the prognosis of patients with lung squamous cell carcinoma (LUSC), as well as a critical consideration for the choice of treatment strategy. Exploring effective methods for predicting LNM in LUSC may benefit clinical decision making. MATERIALS AND METHODS: We used data collected from the Surveillance, Epidemiology, and End Results (SEER) database to develop machine learning algorithm classifiers, including boosted trees (BTs), based on the primary clinical parameters of patients to predict LNM in LUSC...
December 1, 2023: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38129269/-the-contribution-of-artificial-intelligence-ai-subsequent-to-the-processing-of-thoracic-imaging
#44
REVIEW
P A Grenier, A L Brun, F Mellot
The contribution of artificial intelligence (AI) to medical imaging is currently the object of widespread experimentation. The development of deep learning (DL) methods, particularly convolution neural networks (CNNs), has led to performance gains often superior to those achieved by conventional methods such as machine learning. Radiomics is an approach aimed at extracting quantitative data not accessible to the human eye from images expressing a disease. The data subsequently feed machine learning models and produce diagnostic or prognostic probabilities...
December 20, 2023: Revue des Maladies Respiratoires
https://read.qxmd.com/read/38124086/particle-filter-based-parameter-estimation-algorithm-for-prognostic-risk-assessment-of-progression-in-non-small-cell-lung-cancer
#45
JOURNAL ARTICLE
Shi Shang, Junyi Yuan, Changqing Pan, Sufen Wang, Xuemin Tu, Xingxing Cen, Linhui Mi, Xumin Hou
Non-small cell lung cancer (NSCLC) is a malignant tumor that threatens human life and health. The development of a new NSCLC risk assessment model based on electronic medical records has great potential for reducing the risk of cancer recurrence. In this process, machine learning is a powerful method for automatically extracting risk factors and indicating impact weights for NSCLC deaths. However, when the number of samples reaches a certain value, it is difficult for machine learning to improve the prediction accuracy, and it is also challenging to use the characteristic data of subsequent patients effectively...
December 20, 2023: BMC Medical Informatics and Decision Making
https://read.qxmd.com/read/38095634/single-cell-dissection-reveals-the-role-of-aggrephagy-patterns-in-tumor-microenvironment-components-aiding-predicting-prognosis-and-immunotherapy-on-lung-adenocarcinoma
#46
JOURNAL ARTICLE
Xinti Sun, Fei Meng, Minyu Nong, Hao Fang, Chenglu Lu, Yan Wang, Peng Zhang
BACKGROUND: Lung adenocarcinoma (LUAD) is one of the leading malignant cancers. Aggrephagy plays a critical role in key genetic events for various cancers; yet, how aggrephagy functions within the tumor microenvironment (TME) in LUAD remains to be elucidated. METHODS: In this study, by sequential non-negative matrix factorization (NMF) algorithm, pseudotime analysis, cell-cell interaction analysis, and SCENIC analysis, we have shown that aggrephagy genes demonstrated various patterns among different cell types in LUAD TME...
December 13, 2023: Aging
https://read.qxmd.com/read/38094613/new-research-progress-on-18f-fdg-pet-ct-radiomics-for-egfr-mutation-prediction-in-lung-adenocarcinoma-a-review
#47
REVIEW
Xinyu Ge, Jianxiong Gao, Rong Niu, Yunmei Shi, Xiaoliang Shao, Yuetao Wang, Xiaonan Shao
Lung cancer, the most frequently diagnosed cancer worldwide, is the leading cause of cancer-associated deaths. In recent years, significant progress has been achieved in basic and clinical research concerning the epidermal growth factor receptor (EGFR), and the treatment of lung adenocarcinoma has also entered a new era of individualized, targeted therapies. However, the detection of lung adenocarcinoma is usually invasive. 18F-FDG PET/CT can be used as a noninvasive molecular imaging approach, and radiomics can acquire high-throughput data from standard images...
2023: Frontiers in Oncology
https://read.qxmd.com/read/38088837/-predictive-model-for-additional-intraoperative-placement-of-chest-drainage-after-thoracoscopic-lobectomy
#48
JOURNAL ARTICLE
O V Pikin, A B Ryabov, O A Alexandrov, D A Larionov, A A Martynov, E A Toneev
OBJECTIVE: To create a prognostic model determining the risk of tension pneumothorax and the need for intraoperative installation of additional drainage after thoracoscopic lobectomy. MATERIAL AND METHODS: A retrospective multiple-center study included patients who underwent thoracoscopic lobectomy for lung cancer between 2016 and 2022. One drainage tube was used after surgery in all cases. We synthesized data to expand patient selection using the Riley method and machine learning algorithm...
2023: Khirurgiia
https://read.qxmd.com/read/38071529/machine-learning-based-image-analysis-algorithms-improve-interpathologist-concordance-when-scoring-pd-l1-expression-in-non-small-cell-lung-cancer
#49
JOURNAL ARTICLE
Alexander Haragan, Piya Parashar, Danielle Bury, Gregory Cross, John R Gosney
Programmed death ligand 1 (PD-L1) expression on tumour cells is the only predictive biomarker of response to immuno-modulatory therapy for patients with non-small-cell lung cancer (NSCLC). Accuracy of this biomarker is hampered by its challenging interpretation. Here we explore if the use of machine-learning derived image analysis tools can improve interpathologist concordance of assessing PD-L1 expression in NSCLC.Five pathologists who routinely score PD-L1 at a major regional referral hospital for thoracic surgery participated...
December 6, 2023: Journal of Clinical Pathology
https://read.qxmd.com/read/38066711/predictonco-a-web-tool-supporting-decision-making-in-precision-oncology-by-extending-the-bioinformatics-predictions-with-advanced-computing-and-machine-learning
#50
JOURNAL ARTICLE
Jan Stourac, Simeon Borko, Rayyan T Khan, Petra Pokorna, Adam Dobias, Joan Planas-Iglesias, Stanislav Mazurenko, Gaspar Pinto, Veronika Szotkowska, Jaroslav Sterba, Ondrej Slaby, Jiri Damborsky, David Bednar
PredictONCO 1.0 is a unique web server that analyzes effects of mutations on proteins frequently altered in various cancer types. The server can assess the impact of mutations on the protein sequential and structural properties and apply a virtual screening to identify potential inhibitors that could be used as a highly individualized therapeutic approach, possibly based on the drug repurposing. PredictONCO integrates predictive algorithms and state-of-the-art computational tools combined with information from established databases...
November 22, 2023: Briefings in Bioinformatics
https://read.qxmd.com/read/38055320/risk-prediction-of-emergency-department-visits-in-patients-with-lung-cancer-using-machine-learning-retrospective-observational-study
#51
JOURNAL ARTICLE
Ah Ra Lee, Hojoon Park, Aram Yoo, Seok Kim, Leonard Sunwoo, Sooyoung Yoo
BACKGROUND: Patients with lung cancer are among the most frequent visitors to emergency departments due to cancer-related problems, and the prognosis for those who seek emergency care is dismal. Given that patients with lung cancer frequently visit health care facilities for treatment or follow-up, the ability to predict emergency department visits based on clinical information gleaned from their routine visits would enhance hospital resource utilization and patient outcomes. OBJECTIVE: This study proposed a machine learning-based prediction model to identify risk factors for emergency department visits by patients with lung cancer...
December 6, 2023: JMIR Medical Informatics
https://read.qxmd.com/read/38042812/clinico-biological-radiomics-cbr-based-machine-learning-for-improving-the-diagnostic-accuracy-of-fdg-pet-false-positive-lymph-nodes-in-lung-cancer
#52
RANDOMIZED CONTROLLED TRIAL
Caiyue Ren, Fuquan Zhang, Jiangang Zhang, Shaoli Song, Yun Sun, Jingyi Cheng
BACKGROUND: The main problem of positron emission tomography/computed tomography (PET/CT) for lymph node (LN) staging is the high false positive rate (FPR). Thus, we aimed to explore a clinico-biological-radiomics (CBR) model via machine learning (ML) to reduce FPR and improve the accuracy for predicting the hypermetabolic mediastinal-hilar LNs status in lung cancer than conventional PET/CT. METHODS: A total of 260 lung cancer patients with hypermetabolic mediastinal-hilar LNs (SUVmax ≥ 2...
December 2, 2023: European Journal of Medical Research
https://read.qxmd.com/read/38025809/recurrence-prediction-of-lung-adenocarcinoma-using-an-immune-gene-expression-and-clinical-data-trained-and-validated-support-vector-machine-classifier
#53
JOURNAL ARTICLE
Yingran Shen, Chandra Goparaju, Yang Yang, Benson A Babu, Weiming Gai, Harvey Pass, Gening Jiang
BACKGROUND: Immune microenvironment plays a critical role in cancer from onset to relapse. Machine learning (ML) algorithm can facilitate the analysis of lab and clinical data to predict lung cancer recurrence. Prompt detection and intervention are crucial for long-term survival in lung cancer relapse. Our study aimed to evaluate the clinical and genomic prognosticators for lung cancer recurrence by comparing the predictive accuracy of four ML models. METHODS: A total of 41 early-stage lung cancer patients who underwent surgery between June 2007 and October 2014 at New York University Langone Medical Center were included (with recurrence, n=16; without recurrence, n=25)...
October 31, 2023: Translational Lung Cancer Research
https://read.qxmd.com/read/38000327/xl-1-r-net-explainable-ai-driven-improved-l-1-regularized-deep-neural-architecture-for-nsclc-biomarker-identification
#54
JOURNAL ARTICLE
Kountay Dwivedi, Ankit Rajpal, Sheetal Rajpal, Virendra Kumar, Manoj Agarwal, Naveen Kumar
BACKGROUND AND OBJECTIVE: Non-small cell lung cancer (NSCLC) exhibits intrinsic molecular heterogeneity, primarily driven by the mutation of specific biomarkers. Identification of these biomarkers would assist not only in distinguishing NSCLC into its major subtypes - Adenocarcinoma and Squamous Cell Carcinoma, but also in developing targeted therapy. Medical practitioners use one or more types of omic data to identify these biomarkers, copy number variation (CNV) being one such type...
November 23, 2023: Computational Biology and Chemistry
https://read.qxmd.com/read/37999942/synthetic-tabular-data-based-on-generative-adversarial-networks-in-health-care-generation-and-validation-using-the-divide-and-conquer-strategy
#55
JOURNAL ARTICLE
Ha Ye Jin Kang, Erdenebileg Batbaatar, Dong-Woo Choi, Kui Son Choi, Minsam Ko, Kwang Sun Ryu
BACKGROUND: Synthetic data generation (SDG) based on generative adversarial networks (GANs) is used in health care, but research on preserving data with logical relationships with synthetic tabular data (STD) remains challenging. Filtering methods for SDG can lead to the loss of important information. OBJECTIVE: This study proposed a divide-and-conquer (DC) method to generate STD based on the GAN algorithm, while preserving data with logical relationships. METHODS: The proposed method was evaluated on data from the Korea Association for Lung Cancer Registry (KALC-R) and 2 benchmark data sets (breast cancer and diabetes)...
November 24, 2023: JMIR Medical Informatics
https://read.qxmd.com/read/37996894/improving-the-prediction-of-spreading-through-air-spaces-stas-in-primary-lung-cancer-with-a-dynamic-dual-delta-hybrid-machine-learning-model-a-multicenter-cohort-study
#56
JOURNAL ARTICLE
Weiqiu Jin, Leilei Shen, Yu Tian, Hongda Zhu, Ningyuan Zou, Mengwei Zhang, Qian Chen, Changzi Dong, Qisheng Yang, Long Jiang, Jia Huang, Zheng Yuan, Xiaodan Ye, Qingquan Luo
BACKGROUND: Reliable pre-surgical prediction of spreading through air spaces (STAS) in primary lung cancer is essential for precision treatment and surgical decision-making. We aimed to develop and validate a dual-delta deep-learning and radiomics model based on pretreatment computed tomography (CT) image series to predict the STAS in patients with lung cancer. METHOD: Six hundred seventy-four patients with pre-surgery CT follow-up scans (with a minimum interval of two weeks) and primary lung cancer diagnosed by surgery were retrospectively recruited from three Chinese hospitals...
November 23, 2023: Biomarker Research
https://read.qxmd.com/read/37978566/extracellular-vesicle-based-liquid-biopsy-biomarkers-and-their-application-in-precision-immuno-oncology
#57
REVIEW
Karama Asleh, Valerie Dery, Catherine Taylor, Michelle Davey, Marie-Ange Djeungoue-Petga, Rodney J Ouellette
While the field of precision oncology is rapidly expanding and more targeted options are revolutionizing cancer treatment paradigms, therapeutic resistance particularly to immunotherapy remains a pressing challenge. This can be largely attributed to the dynamic tumor-stroma interactions that continuously alter the microenvironment. While to date most advancements have been made through examining the clinical utility of tissue-based biomarkers, their invasive nature and lack of a holistic representation of the evolving disease in a real-time manner could result in suboptimal treatment decisions...
November 17, 2023: Biomarker Research
https://read.qxmd.com/read/37977890/development-and-validation-of-a-machine-learning-based-model-using-ct-radiomics-for-predicting-immune-checkpoint-inhibitor-related-pneumonitis-in-patients-with-nsclc-receiving-anti-pd1-immunotherapy-a-multicenter-retrospective-casecontrol-study
#58
JOURNAL ARTICLE
Guo-Yue Zhang, Xian-Zhi Du, Rui Xu, Ting Chen, Yue Wu, Xiao-Juan Wu, Shui Liu
RATIONALE AND OBJECTIVES: This study aimed to develop and evaluate a radiomics-based model combined with clinical and qualitative radiological (semantic feature [SF]) features to predict immune checkpoint inhibitor-related pneumonitis (CIP) in patients with non-small cell lung cancer (NSCLC) treated with programmed cell death protein 1 inhibitors. MATERIALS AND METHODS: This was a multicenter retrospective casecontrol study conducted from January 1, 2018, to December 31, 2022, at three centers...
November 15, 2023: Academic Radiology
https://read.qxmd.com/read/37958411/artificial-intelligence-and-lung-cancer-impact-on-improving-patient-outcomes
#59
REVIEW
Zainab Gandhi, Priyatham Gurram, Birendra Amgai, Sai Prasanna Lekkala, Alifya Lokhandwala, Suvidha Manne, Adil Mohammed, Hiren Koshiya, Nakeya Dewaswala, Rupak Desai, Huzaifa Bhopalwala, Shyam Ganti, Salim Surani
Lung cancer remains one of the leading causes of cancer-related deaths worldwide, emphasizing the need for improved diagnostic and treatment approaches. In recent years, the emergence of artificial intelligence (AI) has sparked considerable interest in its potential role in lung cancer. This review aims to provide an overview of the current state of AI applications in lung cancer screening, diagnosis, and treatment. AI algorithms like machine learning, deep learning, and radiomics have shown remarkable capabilities in the detection and characterization of lung nodules, thereby aiding in accurate lung cancer screening and diagnosis...
October 31, 2023: Cancers
https://read.qxmd.com/read/37932182/an-integrated-model-combined-intra-and-peritumoral-regions-for-predicting-chemoradiation-response-of-non-small-cell-lung-cancers-based-on-radiomics-and-deep-learning
#60
JOURNAL ARTICLE
Y Ma, Q Li
PURPOSE: The purpose of this study was to develop a model for predicting chemoradiation response in non-small cell lung cancer (NSCLC) patients by integrating radiomics and deep-learning features and combined intra- and peritumoral regions with pre-treated CT images. MATERIALS AND METHODS: This study enrolled 462 patients with NSCLC who received chemoradiation. On the basis of pretreated CT images, we developed three models to compare the prediction of chemoradiation: intratumoral, peritumoral and combined regions...
November 4, 2023: Cancer Radiothérapie: Journal de la Société Française de Radiothérapie Oncologique
keyword
keyword
167541
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.